Favorable long term effects of intensified immunosuppression combined with therapeutic plasma exchange in patients with early-onset progressive systemic sclerosis-related interstitial lung disease()

OBJECTIVE: Systemic sclerosis (SSc) related mortality and morbidity remains high. Immunosuppressive therapy is considered most effective when immune activity and inflammation but not fibrosis still dominates the disease process. This study evaluated long-term intensified immunosuppression combined w...

Descripción completa

Detalles Bibliográficos
Autores principales: Potjewijd, J., Tobal, R., Silvertand, D., Gietema, H.A., Damoiseaux, J.G.M.C., van Paassen, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
VSI:Autoantibodies in disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706153/
https://www.ncbi.nlm.nih.gov/pubmed/36458101
http://dx.doi.org/10.1016/j.jtauto.2022.100174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706153/
https://www.ncbi.nlm.nih.gov/pubmed/36458101
http://dx.doi.org/10.1016/j.jtauto.2022.100174

Ejemplares similares